SGLT2 Inhibitors and Mechanisms of Hypertension

被引：0
|
作者：
Alexandros Briasoulis
Omar Al Dhaybi
George L. Bakris
机构：
[1] University of Iowa Hospitals and Clinics,Department of Cardiovascular Medicine
[2] The University of Chicago Medicine,ASH Comprehensive Hypertension Center
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Diabetes; Hypertension; Glucose; Transporters; SGLT2; Cardiovascular events; Weight loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SGLT2 Inhibitors and Mechanisms of Hypertension
    Briasoulis, Alexandros
    Al Dhaybi, Omar
    Bakris, George L.
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (01)
  • [2] SGLT2 inhibitors: not for hypertension but exceedingly useful in hypertension
    Messerli, Franz H.
    Schoenenberger-Berzins, Renate
    Burnier, Michel
    EUROPEAN HEART JOURNAL, 2025, 46 (14) : 1318 - 1320
  • [3] Are SGLT2 Inhibitors New Hypertension Drugs?
    Kario, Kazuomi
    Ferdinand, Keith C.
    Vongpatanasin, Wanpen
    CIRCULATION, 2021, 143 (18) : 1750 - 1753
  • [4] Possible renoprotective mechanisms of SGLT2 inhibitors
    Nishiyama, Akira
    Kitada, Kento
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] SGLT2 inhibitors and the kidney: Effects and mechanisms
    Tsimihodimos, V.
    Filippatos, T. D.
    Elisaf, M. S.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (06) : 1117 - 1123
  • [6] SGLT2 Inhibitors in Resistant Hypertension: A Sweet Solution
    Tran, Karen C.
    Hiremath, Swapnil
    AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (12) : 1071 - 1074
  • [7] Potential role of SGLT2 inhibitors in the management of hypertension
    Salmasi, Shahrzad
    Yu, Oriana H. Y.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 487 - 489
  • [8] SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives
    Tan, Jiang-Shan
    Wei, Yixiao
    Chong, Lingtao
    Yang, Yanmin
    Hu, Song
    Wang, Yimeng
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (08) : 709 - 725
  • [9] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [10] Possible mechanisms of cardiovascular benefits of SGLT2 inhibitors
    Verges, B.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2019, 11 : S18 - S22
12345